Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment.
Cancer Med
; 8(13): 5939-5947, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31433117
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acrylamides
/
Adenocarcinoma
/
Carcinoma, Non-Small-Cell Lung
/
Protein Kinase Inhibitors
/
Circulating Tumor DNA
/
Aniline Compounds
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Med
Year:
2019
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Estados Unidos